DermTech, Inc. (DMTKQ) vs T2 Biosystems, Inc. (TTOO)
DermTech, Inc. and T2 Biosystems, Inc. are both Diagnostics & Research companies. T2 Biosystems, Inc. is the larger, with a market value of $6.5M against $3.3M — 2.0× the size. DermTech, Inc. grew revenue faster over the last twelve months: 9.71% against −30.2%. T2 Biosystems, Inc. has the higher net margin (−559.5% vs −572.2%) and the higher return on invested capital (0.00% vs −5,493.5%). Across the 14 metrics below, DermTech, Inc. leads on 7 and T2 Biosystems, Inc. on 7.
Valuation
Profitability
| Metric | DMTKQ | TTOO | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 8.51% | (76.76%) | 50.89% |
| Operating margin | (588.62%) | (542.59%) | (8.57%) |
| Net margin | (572.19%) | (559.52%) | (6.37%) |
| Free cash flow margin | (460.10%) | (476.64%) | 0.00% |
| Return on equity | (121.75%) | 277.61% | (2.92%) |
| Return on assets | (64.00%) | (140.00%) | (6.71%) |
| Return on invested capital | (5,493.45%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack